Imre says idiopathic thrombocytopenic purpura (ITP) patients benefit from Prosorba column
This article was originally published in Clinica
Executive Summary
Results from an Imre study reveal the company's Prosorba column may be effective in the treatment of idiopathic thrombocytopenic purpura. The bleeding disorder affects some 300,000 patients in the US and Europe each year.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.